Latest Regulatory Matters News

Page 4 of 4
Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.
Victor Sage
Victor Sage
14 May 2025
Range International reported a 51% revenue increase in Q1 2025 despite supply chain disruptions that dented cash flow. The company is advancing growth initiatives including pallet rentals in Indonesia and expanding production to the Philippines.
Victor Sage
Victor Sage
29 Apr 2025
Holista Colltech has closed its ASIC penalty chapter with a $900K final payment, raised $1.53 million through convertible notes, and reported a 10.9% year-on-year sales increase driven by its Dietary Supplements division.
Ada Torres
Ada Torres
29 Apr 2025
ASX Limited reported a solid half-year performance for 1H25, with operating revenue up 5.9% to $541.9 million and an interim dividend increase to 111.2 cents per share. The company continues to invest heavily in technology upgrades while navigating ongoing regulatory scrutiny.
Claire Turing
Claire Turing
13 Feb 2025
Hastings Technology Metals has secured a strategic non-binding MOU with Saudi Arabia’s Ministry of Investment to explore a rare earths processing facility, while reporting encouraging developments at its Yangibana Project and maintaining solid financial footing.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Advance Metals Limited remains suspended from ASX trading as the exchange awaits full compliance with listing rules tied to its proposed acquisitions and JORC Code adherence.
Maxwell Dee
Maxwell Dee
2 Jan 2025

Browse the archive

Full archive